379 related articles for article (PubMed ID: 32621970)
1. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Petta S; Sebastiani G; Viganò M; Ampuero J; Wai-Sun Wong V; Boursier J; Berzigotti A; Bugianesi E; Fracanzani AL; Cammà C; Enea M; Grottes MD; Di Marco V; Younes R; Keyrouz A; Mazzola S; Mendoza Y; Pennisi G; Romero-Gomez M; Craxì A; de Ledinghen V
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):806-815.e5. PubMed ID: 32621970
[TBL] [Abstract][Full Text] [Related]
2. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
[TBL] [Abstract][Full Text] [Related]
3. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
[TBL] [Abstract][Full Text] [Related]
4. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
[TBL] [Abstract][Full Text] [Related]
5. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
Semmler G; Yang Z; Fritz L; Köck F; Hofer BS; Balcar L; Hartl L; Jachs M; Stopfer K; Schedlbauer A; Neumayer D; Maurer J; Müllner-Bucsics T; Simbrunner B; Scheiner B; Trauner M; Mandorfer M; Reiberger T; Bauer DJM
Gastroenterology; 2023 Oct; 165(4):1041-1052. PubMed ID: 37442301
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
7. Liver stiffness (Fibroscan®) is a predictor of all-cause mortality in people with non-alcoholic fatty liver disease.
Braude M; Roberts S; Majeed A; Lubel J; Prompen J; Dev A; Sievert W; Bloom S; Gow P; Kemp W
Liver Int; 2023 Jan; 43(1):90-99. PubMed ID: 36050821
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
Pons M; Rodríguez-Tajes S; Esteban JI; Mariño Z; Vargas V; Lens S; Buti M; Augustin S; Forns X; Mínguez B; Genescà J
J Hepatol; 2020 Mar; 72(3):472-480. PubMed ID: 31629779
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease.
Mendoza Y; Cocciolillo S; Murgia G; Chen T; Margini C; Sebastiani G; Berzigotti A
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3017-3025.e6. PubMed ID: 32289534
[TBL] [Abstract][Full Text] [Related]
10. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis.
Eaton JE; Sen A; Hoodeshenas S; Schleck CD; Harmsen WS; Gores GJ; LaRusso NF; Gossard AA; Lazaridis KN; Venkatesh SK
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1576-1583.e1. PubMed ID: 31683058
[TBL] [Abstract][Full Text] [Related]
11. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571
[TBL] [Abstract][Full Text] [Related]
12. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
Ajmera V; Kim BK; Yang K; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Quach NE; Tu X; Zhang X; Noureddin M; Allen AM; Loomba R
Gastroenterology; 2022 Oct; 163(4):1079-1089.e5. PubMed ID: 35788349
[TBL] [Abstract][Full Text] [Related]
13. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.
Kim SU; Lee JH; Kim DY; Ahn SH; Jung KS; Choi EH; Park YN; Han KH; Chon CY; Park JY
PLoS One; 2012; 7(5):e36676. PubMed ID: 22574212
[TBL] [Abstract][Full Text] [Related]
14. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
15. Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease.
Scheiner B; Steininger L; Semmler G; Unger LW; Schwabl P; Bucsics T; Paternostro R; Ferlitsch A; Trauner M; Reiberger T; Mandorfer M
Liver Int; 2019 Jan; 39(1):127-135. PubMed ID: 30107095
[TBL] [Abstract][Full Text] [Related]
16. Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
Lee SW; Huang DQ; Bettencourt R; Ajmera V; Tincopa M; Noureddin N; Amangurbanova M; Siddiqi H; Madamba E; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Yoneda M; Idilman R; Gumussoy M; Oz DK; Erden A; Loomba R
Aliment Pharmacol Ther; 2024 Jan; 59(1):80-88. PubMed ID: 37968251
[TBL] [Abstract][Full Text] [Related]
17. Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
Elhence A; Anand A; Biswas S; Vaishnav M; Yadav R; Das P; Panwar R; Agarwal S; Gamanagatti S; Kumar R; Shalimar
Dig Dis Sci; 2023 Mar; 68(3):1016-1025. PubMed ID: 35670897
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study.
Cardoso CRL; Villela-Nogueira CA; Leite NC; Salles GF
Cardiovasc Diabetol; 2021 Sep; 20(1):193. PubMed ID: 34560854
[TBL] [Abstract][Full Text] [Related]
19. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease.
Thorhauge KH; Semmler G; Johansen S; Lindvig KP; Kjærgaard M; Hansen JK; Torp N; Hansen CD; Andersen P; Hofer BS; Gu W; Israelsen M; Mandorfer M; Reiberger T; Trebicka J; Thiele M; Krag A;
J Hepatol; 2024 Feb; ():. PubMed ID: 38428644
[TBL] [Abstract][Full Text] [Related]
20. FIB-4 Improves LSM-Based Prediction of Complications in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease.
Mendoza YP; Shengir M; Bosch J; Sebastiani G; Berzigotti A
Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2396-2398.e3. PubMed ID: 33716139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
